Larvol Delta - MATEON-THERAPEUTICS-TEAM-PUBLISHES-A-NEW-PEERREVIEWED-ONCOLOGY-ARTICLE-ON-THE-POSITIVE-CLINICAL-STUDY-RESULTS-FOR-OT101-AGAINST-RECALCITRANT-RESISTANT-ANAPLASTIC-ASTROCYTOMA--A-RARE-FORM-OF-MALIGNANT-BRAIN-TUMOR

trabedersen (OT-101) - Autotelic, Mateon Therapeutics

temozolomide - Generic mfg.

http://www.globenewswire.com/news-release/2020/04/02/2010740/0/en/MATEON-THERAPEUTICS-TEAM-PUBLISHES-A-NEW-PEER-REVIEWED-ONCOLOGY-ARTICLE-ON-THE-POSITIVE-CLINICAL-STUDY-RESULTS-FOR-OT-101-AGAINST-RECALCITRANT-RESISTANT-ANAPLASTIC-ASTROCYTOMA-A-RA.html

Apr 2, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next